• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

suzuki yutaro  鈴木 雄太郎

ORCIDConnect your ORCID iD *help
… Alternative Names

Suzuki Yutaro  鈴木 雄太郎

SUZUKI Yutaro  鈴木 雄太郎

Less
Researcher Number 60377158
External Links
Affiliation (Current) 2025: 新潟大学, 医歯学総合研究科, 客員研究員
2025: 新潟大学, 医歯学総合病院, 医員
2025: 新潟大学, 医学部, 非常勤講師
Affiliation (based on the past Project Information) *help 2021 – 2023: 新潟大学, 医歯学総合研究科, 客員研究員
2018 – 2019: 新潟大学, 医歯学総合病院, 特任教授
2005 – 2017: 新潟大学, 医歯学総合病院, 講師
Review Section/Research Field
Principal Investigator
Psychiatric science / Basic Section 52030:Psychiatry-related
Except Principal Investigator
Psychiatric science
Keywords
Principal Investigator
うつ病 / 副作用 / 病態生理学 / 臨床 / 精神医学 / IGF-1 / ホルモン / 治療抵抗性 / 糖脂質代謝異常 / 抗精神病薬 … More / ゲノム / 抗うつ薬 / 薬理遺伝学 / 治療反応性 / 遺伝子多型 / 新規抗うつ薬 / DHEAS / インスリン抵抗性 / 再発 / 自殺リスク / DHEA-S / 耐糖能異常 / 薬物療法 / コルチゾール/DHEAS比 / 性腺機能 / prolactin / cortisol / 重症度 / 統合失調症 / ホルモン補充療法 / 性ホルモン / 青年期 / 単純型統合失調症 / 認知機能障害 / 副作用予防 / アディポカイン / 肥満 / 糖尿病 / schizophrenia / obesity / genetic polymorphism / adipokine / metabolic side effect / antipsychotics / 新規抗精神病薬 / 臨床効果 / アデイポカイン / QT延長 / 高プロラクチン血症 / 第2世代抗精神病薬 / 薬遺伝学 / 臨床精神薬理 / 薬力学 / 薬理動態学 / フルボキサミン / 寛解 / 血中濃度 / テーラーメイド治療 / うつ病治療 / ゲノム医学 / 難治化 / テーラーメイド薬物療法 / 薬剤反応性 / ABCB1 / CYP2D6 / セロトニン2A受容体 … More
Except Principal Investigator
prolactin / オランザピン / 統合失調症 / 新規抗精神病薬 / Taq1A gene / dopamine D2 receptor / clinical response / glucose intolerance / schizophrenia / novel antipsychotics / leptin / insulin / perospirone / olanzapine / 総合失調症 / Taq1遺伝子多型 / 臨床効果 / ペロスピロン / プロラクチン / Taq1A遺伝子 / ドーパミンD2受容体 / 治療反応性 / 耐糖能異常 / 生物学的マーカー / メタボリックシンドローム(MS) / 薬物動態学 / 薬力学 / 75gOGTT / メタボリックシンドローム Less
  • Research Projects

    (9 results)
  • Research Products

    (158 results)
  • Co-Researchers

    (5 People)
  •  The elucidation of the mechanisms underlying treatment-resistant depression by steroid and peptide hormonesPrincipal Investigator

    • Principal Investigator
      Suzuki Yutaro
    • Project Period (FY)
      2021 – 2023
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 52030:Psychiatry-related
    • Research Institution
      Niigata University
  •  Elucidation of pathophysiology of refractory psychiatric disorders using HPG/HPA interaction and hormone replacement therapy responsivenessPrincipal Investigator

    • Principal Investigator
      Suzuki Yuutarou
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Psychiatric science
    • Research Institution
      Niigata University
  •  Cognitive dysfunction with onset in youth focused on simple schizophrenia as a prototypePrincipal Investigator

    • Principal Investigator
      Suzuki Yutaro
    • Project Period (FY)
      2014 – 2016
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Psychiatric science
    • Research Institution
      Niigata University
  •  Effect of antipsychotics on metabolic and cardiac side effects in Japanese patients with schizophreniaPrincipal Investigator

    • Principal Investigator
      SUZUKI Yutaro
    • Project Period (FY)
      2011 – 2014
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Psychiatric science
    • Research Institution
      Niigata University
  •  Predictors of side effects induced by second generation antipsychoticsPrincipal Investigator

    • Principal Investigator
      SUZUKI Yutaro, 澤村 一司
    • Project Period (FY)
      2008 – 2010
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Psychiatric science
    • Research Institution
      Niigata University
  •  Pharmacogenomics of antidepressant response and adverse effectsPrincipal Investigator

    • Principal Investigator
      SUZUKI Yutaro
    • Project Period (FY)
      2007 – 2008
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Psychiatric science
    • Research Institution
      Niigata University
  •  The effect of newel antipsychotic drugs on the Incidente of metabolic syndrome

    • Principal Investigator
      SOMEYA Toshiyuki
    • Project Period (FY)
      2007 – 2008
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Psychiatric science
    • Research Institution
      Niigata University
  •  うつ病の薬物治療反応性マーカーに関する分子薬理ゲノム研究Principal Investigator

    • Principal Investigator
      鈴木 雄太郎
    • Project Period (FY)
      2005 – 2006
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Psychiatric science
    • Research Institution
      Niigata University
  •  The search of the gene polymorphism associated with glycolipid metabolism dysfunction in schizophrenic patients with novel antipsychotics

    • Principal Investigator
      SOMEYA Toshiyuki
    • Project Period (FY)
      2005 – 2006
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Psychiatric science
    • Research Institution
      Niigata University

All 2024 2023 2022 2021 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 Other

All Journal Article Presentation Book

  • [Book] うつ病の治療. 専門医のための臨床精神神経薬理学テキスト.2021

    • Author(s)
      田尻美寿々, 鈴木雄太郎
    • Total Pages
      10
    • Publisher
      星和書店, 東京
    • Data Source
      KAKENHI-PROJECT-21K07478
  • [Book] 統合失調症の100のQ&A (藤井康男編)2008

    • Author(s)
      渡邉純蔵, 福井直樹, 鈴木雄太郎, 染矢俊幸
    • Publisher
      星和書店, 東京
    • Data Source
      KAKENHI-PROJECT-19591344
  • [Book] 統合失調症の薬物療法1GOのQ&A2008

    • Author(s)
      渡邉純蔵, 福井直樹, 鈴木雄太郎, 染矢俊幸
    • Publisher
      星和書店
    • Data Source
      KAKENHI-PROJECT-19591344
  • [Book] 新規抗精神病薬と他の薬との相互作用で注意すべき点は?統合失調症の薬物療法100のQ&A(藤井康男編)2008

    • Author(s)
      熊田智, 須貝拓朗, 鈴木雄太郎, 染矢俊幸
    • Publisher
      星和書店
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Book] 統合失調症の兄がオランザピンでとてもよく改善したのですが,弟にも同じ病気が発病しました.このような場合は,兄の抗精神病薬への反応性(効果や副作用)が,弟のそれを予測するのに参考になるのでしょうか?統合失調症の薬物療法100のQ&A(藤井康男編).2008

    • Author(s)
      渡邉純蔵, 福井直樹, 鈴木雄太郎, 染矢俊幸
    • Publisher
      星和書店
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] Association between insulin resistance and serum insulin-like growth factor 1 levels in patients with non-remitting major depressive disorder2024

    • Author(s)
      Arinami Hiroshi、Suzuki Yutaro、Watanabe Yuichiro、Tajiri Misuzu、Tsuneyama Nobuto、Someya Toshiyuki
    • Journal Title

      Journal of Affective Disorders

      Volume: 344 Pages: 612-616

    • DOI

      10.1016/j.jad.2023.10.009

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K07478
  • [Journal Article] Serum cortisol and insulin-like growth factor 1 levels in major depressive disorder and schizophrenia2023

    • Author(s)
      Arinami Hiroshi、Watanabe Yuichiro、Suzuki Yutaro、Tajiri Misuzu、Tsuneyama Nobuto、Someya Toshiyuki
    • Journal Title

      Scientific Reports

      Volume: 13 Issue: 1 Pages: 1148-1148

    • DOI

      10.1038/s41598-023-28449-8

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K07478, KAKENHI-PROJECT-20H03597
  • [Journal Article] Hormonal Dynamics Effect of Serum Insulin-Like Growth Factor I and Cortisol/Dehydroepiandrosterone Sulfate Ratio on Symptom Severity of Major Depressive Disorder.2019

    • Author(s)
      Tajiri M, Suzuki Y, Tsuneyama N, Arinami H, Someya T:
    • Journal Title

      J Clin Psychopharmacol

      Volume: 39(4) Issue: 4 Pages: 367-371

    • DOI

      10.1097/jcp.0000000000001071

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19K17085, KAKENHI-PROJECT-17K10268
  • [Journal Article] Hormonal dynamics effect of serum IGF-I and cortisol / DHEAS raio on symptom severity of major depressive disorder2019

    • Author(s)
      Misuzu Tajiri, Yutaro Suzuki, Nobuto Tsuneyama, Hiroshi Arinami, Toshiyuki Someya
    • Journal Title

      Journal of Clinical Psychopharmacology

      Volume: in press

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K10268
  • [Journal Article] Effect of Serum Leptin on Weight Gain Induced by Olanzapine in Female Patients with Schizophrenia.2016

    • Author(s)
      Tsuneyama N, Suzuki Y, Sawamura K, Sugai T, Fukui N, Watanabe J, Ono S, Saito M, Someya T.
    • Journal Title

      PLoS One

      Volume: 11 Issue: 3 Pages: e0149518-e0149518

    • DOI

      10.1371/journal.pone.0149518

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-26461715
  • [Journal Article] GIPR Gene Polymorphism and Weight Gain in Patients With Schizophrenia Treated With Olanzapine2015

    • Author(s)
      Ono S, Suzuki Y, Fukui N, Sawamura K, Sugai T, Watanabe J, Tsuneyama N, Someya T
    • Journal Title

      The Journal of Neuropsychiatry and Clinical Neurosciences

      Volume: 27 Pages: 162-4

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Journal Article] Improvement of dumping syndrome and oversecretion of glucose-dependent insulinotropic polypeptide following a switch from olanzapine to quetiapine in a patient with schizophrenia2015

    • Author(s)
      Watanabe A, Fukui N, Suzuki Y, Motegi T, Igeta H, Tsuneyama N, Someya T
    • Journal Title

      General Hospital Psychiatry

      Volume: 印刷中

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Journal Article] Psychiatrists' attitudes toward metabolic adverse events in patients with schizophrenia2014

    • Author(s)
      Sugawara N, Yasui-Furukori N, Yamazaki M, Shimoda K, Mori T, Sugai T, Suzuki Y, Someya T
    • Journal Title

      PLoS One

      Volume: 23

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Journal Article] Effects of olanzapine on the PR and QT intervals in patients with schizophrenia.2014

    • Author(s)
      Suzuki Y, Ono S, Tsuneyama N, Sawamura K, Sugai T, Fukui N, Watanabe J, Someya T.
    • Journal Title

      Schizophr Res.

      Volume: 152 Issue: 1 Pages: 313-4

    • DOI

      10.1016/j.schres.2013.10.036

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670, KAKENHI-PROJECT-24791204
  • [Journal Article] Changes in PR and QTc intervals after switching from olanzapine to risperidone in patients with stable schizophrenia.2014

    • Author(s)
      Suzuki Y, Sugai T, Ono S, Sawamura K, Fukui N, Watanabe J, Tsuneyama N, Saito M, Someya T.
    • Journal Title

      Psychiatry Clin Neurosci.

      Volume: 68 Issue: 5 Pages: 353-6

    • DOI

      10.1111/pcn.12136

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-23591670, KAKENHI-PROJECT-26461763
  • [Journal Article] Effect of risperidone metabolism and P-glycoprotein gene polymorphism on QT interval in patients with schizophrenia.2014

    • Author(s)
      Suzuki Y, Tsuneyama N, Fukui N, Sugai T, Watanabe J, Ono S, Saito M, Inoue Y, Someya T.
    • Journal Title

      Pharmacogenomics J.

      Volume: in press Issue: 5 Pages: 452-456

    • DOI

      10.1038/tpj.2014.6

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Journal Article] High prevalence of underweight and undernutrition in Japanese inpatients with schizophrenia.2014

    • Author(s)
      Suzuki Y, Sugai T, Fukui N, Watanabe J, Ono S, Tsuneyama N, Saito M, Someya T.
    • Journal Title

      Psychiatry Clin Neurosci.

      Volume: 68 Issue: 1 Pages: 78-82

    • DOI

      10.1111/pcn.12082

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670, KAKENHI-PROJECT-24791204
  • [Journal Article] Low prevalence of metabolic syndrome and its prediction in Japanese inpatients with schizophrenia.2013

    • Author(s)
      Suzuki Y, Sugai T, Fukui N, Watanabe J, Ono S, Tsuneyama N, Saito M, Someya T.
    • Journal Title

      Hum Psychopharmacol.

      Volume: 28 Issue: 2 Pages: 188-91

    • DOI

      10.1002/hup.2295

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670, KAKENHI-PROJECT-23791314, KAKENHI-PROJECT-24791204, KAKENHI-PROJECT-25461725
  • [Journal Article] Changes in QT interval after switching to quetiapine in Japanese patients with schizophrenia.2013

    • Author(s)
      Suzuki Y, Sugai T, Fukui N, Watanabe J, Ono S, Tsuneyama N, Saito M, Someya T.
    • Journal Title

      Hum Psychopharmacol.

      Volume: 28 Issue: 1 Pages: 94-6

    • DOI

      10.1002/hup.2277

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670, KAKENHI-PROJECT-23791314, KAKENHI-PROJECT-24791204
  • [Journal Article] The prevalence of glucose intolerance in Japanese schizophrenic patients with a normal fasting glucose level.2013

    • Author(s)
      Ono S, Suzuki Y, Fukui N, Sugai T, Watanabe J, Tsuneyama N, Saito M, Someya T.
    • Journal Title

      J Clin Psychopharmacol.

      Volume: 33 Issue: 4 Pages: 525-7

    • DOI

      10.1097/jcp.0b013e3182905775

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670, KAKENHI-PROJECT-24791204, KAKENHI-PROJECT-25461725
  • [Journal Article] Impact of the ABCB1 gene polymorphism on plasma 9-hydroxyrisperidone and active moiety levels in Japanese patients with schizophrenia.2013

    • Author(s)
      Suzuki Y, Tsuneyama N, Fukui N, Sugai T, Watanabe J, Ono S, Saito M, Someya T.
    • Journal Title

      J Clin Psychopharmacol.

      Volume: 33 Issue: 3 Pages: 411-4

    • DOI

      10.1097/jcp.0b013e31828ecd52

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670, KAKENHI-PROJECT-23791314, KAKENHI-PROJECT-24791204
  • [Journal Article] Differences in plasma prolactin levels in patients with schizophrenia treated on monotherapy with five second-generation antipsychotics.2013

    • Author(s)
      Suzuki Y, Sugai T, Fukui N, Watanabe J, Ono S, Tsuneyama N, Saito M, Someya T.
    • Journal Title

      Schizophr Res.

      Volume: 145 Issue: 1-3 Pages: 116-9

    • DOI

      10.1016/j.schres.2012.12.027

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670, KAKENHI-PROJECT-23791314, KAKENHI-PROJECT-24791204
  • [Journal Article] Sex differences in the effect of four second-generation antipsychotics on QTc interval in patients with schizophrenia.2013

    • Author(s)
      Suzuki Y, Sugai T, Fukui N, Watanabe J, Ono S, Tsuneyama N, Saito M, Someya T.
    • Journal Title

      Hum Psychopharmacol.

      Volume: 28 Issue: 3 Pages: 215-9

    • DOI

      10.1002/hup.2309

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670, KAKENHI-PROJECT-24791204
  • [Journal Article] Excessive insulin secretion in Japanese schizophrenic patients treated with antipsychotics despite normal fasting glucose levels.2012

    • Author(s)
      Sugai T, Suzuki Y, Fukui N, Watanabe J, Ono S, Tsuneyama N, Someya T.
    • Journal Title

      J Clin Psychopharmacol. 2012 Dec;32(6):750-5.

      Volume: 32 Issue: 6 Pages: 750-5

    • DOI

      10.1097/jcp.0b013e3182742ea4

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670, KAKENHI-PROJECT-23791314, KAKENHI-PROJECT-24791204
  • [Journal Article] Effect of the cytochrome P450 2D6*10 allele on risperidone metabolism in Japanese psychiatric patients.2012

    • Author(s)
      Suzuki Y, Fukui N, Tsuneyama N, Watanabe J, Ono S, Sugai T, Saito M, Inoue Y, Someya T.
    • Journal Title

      Hum Psychopharmacol.

      Volume: 27 Pages: 43-6

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Journal Article] QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidone.2012

    • Author(s)
      Suzuki Y, Fukui N, Watanabe J, Ono S, Sugai T, Tsuneyama N, Saito M, Inoue Y, Someya T.
    • Journal Title

      Hum Psychopharmacol.

      Volume: 27 Issue: 1 Pages: 39-42

    • DOI

      10.1002/hup.1258

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670, KAKENHI-PROJECT-23791314, KAKENHI-PROJECT-24791204
  • [Journal Article] Dysregulation of adipocytokines related to second-generation antipsychotics in normal fasting glucose patients with schizophrenia.2012

    • Author(s)
      Sugai T, Suzuki Y, Fukui N, Ono S, Watanabe J, Tsuneyama N, Someya T.
    • Journal Title

      J Clin Psychopharmacol.

      Volume: 32 Issue: 3 Pages: 390-3

    • DOI

      10.1097/jcp.0b013e3182524393

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670, KAKENHI-PROJECT-23791314, KAKENHI-PROJECT-24791204
  • [Journal Article] Increased risk of antipsychotic-related QT prolongation during nighttime: a 24-hour holter electrocardiogram recording study2012

    • Author(s)
      Watanabe J, Suzuki Y, Fukui N, Ono S, Sugai T, Tsuneyama N, Someya T.
    • Journal Title

      J Clin Psychopharmacol.

      Volume: 32 Issue: 1 Pages: 18-22

    • DOI

      10.1097/jcp.0b013e31823f6f21

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670, KAKENHI-PROJECT-23791314, KAKENHI-PROJECT-24791204
  • [Journal Article] Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine2012

    • Author(s)
      Ono S, Suzuki Y, Shindo M, Endo T, Fukui N, Sugai T, Someya T.
    • Journal Title

      J Clin Pharm Ther.

      Volume: 37 Issue: 3 Pages: 370-2

    • DOI

      10.1111/j.1365-2710.2011.01290.x

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Journal Article] QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidone.2012

    • Author(s)
      鈴木雄太郎
    • Journal Title

      Hum Psychopharmacol

      Volume: 27 Pages: 39-42

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Journal Article] Association between the GIPR gene and the insulin level after glucose loading in schizophrenia patients treated with olanzapine.2012

    • Author(s)
      Ono S, Suzuki Y, Fukui N, Sugai T, Watanabe J, Tsuneyama N, Someya T.
    • Journal Title

      Pharmacogenomics J.

      Volume: 12 Issue: 6 Pages: 507-12

    • DOI

      10.1038/tpj.2011.28

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670, KAKENHI-PROJECT-23791314
  • [Journal Article] The lipid profiles in Japanese patients with schizophrenia treated with antipsychotic agents.2012

    • Author(s)
      Watanabe J, Suzuki Y, Sugai T, Fukui N, Ono S, Tsuneyama N, Saito M, Someya T.
    • Journal Title

      Gen Hosp Psychiatry.

      Volume: 34 Issue: 5 Pages: 525-8

    • DOI

      10.1016/j.genhosppsych.2012.04.002

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670, KAKENHI-PROJECT-23791314, KAKENHI-PROJECT-24791204
  • [Journal Article] Exploring functional polymorphisms in the dopamine receptor D2 gene using prolactin concentration in healthy subjects.2011

    • Author(s)
      福井直樹, 鈴木雄太郎, 福井直樹, 渡邉純藏, 小野信, 常山暢人, 染矢俊幸
    • Journal Title

      Mol Psychiatry. 16

      Pages: 356-358

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] Dose-dependent increase in the QTc interval in aripiprazole treatment after risperidone.2011

    • Author(s)
      鈴木雄太郎
    • Journal Title

      Prog Neuropsychopharmacol Biol Psychiatry

      Volume: 35 Pages: 643-644

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] 統合失調症治療における非定型抗精神病薬の副作用予測に関する研究2011

    • Author(s)
      鈴木雄太郎
    • Journal Title

      臨床薬理

    • NAID

      10029432955

    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] Dose-dependent effects of olanzapine on QT intervals and plasma prolactin levels in Japanese patients with stable schizophrenia.2011

    • Author(s)
      鈴木雄太郎
    • Journal Title

      Hum Psychopharmacol

      Volume: 印刷中

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Journal Article] Changes in the metabolic parameters and QTc interval after switching from olanzapine to aripiprazole in Japanese patients with stable schizophrenia.2011

    • Author(s)
      鈴木雄太郎
    • Journal Title

      J Clin Psychopharmacol

      Volume: 31 Pages: 526-8

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Journal Article] Changes in the metabolic parameters and QTc interval after switching from olanzapine to aripiprazole in Japanese patients with stable schizophrenia.2011

    • Author(s)
      鈴木雄太郎
    • Journal Title

      J CIin Psychophannacol

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] Gender differences in the relationship between the risperidone metabolism and the plasma prolactin levels in psychiatric patients.2010

    • Author(s)
      鈴木雄太郎
    • Journal Title

      Prog Neuropsychopharmacol Biol Psychiatry

      Volume: 34 Pages: 1266-1268

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] The wide variability of perospirone metabolism and the effect of perospirone on prolactin in psychiatric patients.2010

    • Author(s)
      鈴木雄太郎
    • Journal Title

      Prog Neuropsychopharmacol Biol Psychiatry (印刷中)

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] CYP2D6 genotype and smoking influence fluvoxamine steady-state concentration in Japanese psychiatric patients : lessons for genotype-phenotype association study design in translational pharmacogenetics.2010

    • Author(s)
      Suzuki Y, Sugai T, Fukui N, Watanabe J, Ono S, Inoue Y, Ozdemir V, Someya T
    • Journal Title

      J Psychopharmacol. Epub ahead of print

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] Gender differences in the relationship between the risperidone metabolism and the plasma prolactin levels in psychiatric patients.2010

    • Author(s)
      Suzuki Y, Fukui N, Watanabe J, Ono S, Sugai T, Tsuneyama N, Inoue Y, Someya T
    • Journal Title

      Prog Neuropsychopharmacol Biol Psychiatry. 34

      Pages: 1266-1268

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] Increase in the risk of chlorpromazine-induced QT prolongation during nighttime : Is a short-period ECG during daytime sufficient?2010

    • Author(s)
      鈴木雄太郎
    • Journal Title

      Prog Neuropsychopharmacol Biol Psychiatry (印刷中)

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] Increase in the risk of chlorpromazine-induced QT prolongation during nighttime: Is a short-period ECG during daytime sufficient?2010

    • Author(s)
      鈴木雄太郎, 渡邉純藏, 小野信, 福井直樹, 須貝拓朗, 常山暢人, 染矢俊幸
    • Journal Title

      Prog Neuropsychopharmacol Biol Psychiatry. 34

      Pages: 1122-1123

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] Increase in the risk of chlorpromazine-induced QT prolongation during nighttime: Is a short-period ECG during daytime sufficient?2010

    • Author(s)
      鈴木雄太郎
    • Journal Title

      Prog Neuropsychopharmacol Biol Psychiatry

      Volume: 34 Pages: 1122-1123

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] Differences in clinical effect and tolerance between fluvoxamine and paroxetine : A switching study in patients with depression.2010

    • Author(s)
      鈴木雄太郎, 常山暢人, 福井直樹, 須貝拓朗, 渡邉純藏, 小野信, 染矢俊幸
    • Journal Title

      Hum Psychopharmacol. Epub ahead of print

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] CYP2D6 genotype and smoking influence fluvoxamine steady-state concentration in Japanese psychiatric patients:lessons for genotype-phenotype association study design in translational pharmacogenetics.2010

    • Author(s)
      鈴木雄太郎
    • Journal Title

      J Psychopharmacol

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] The wide variability of perospirone metabolism and the effect of perospirone on prolactin in psychiatric patients.2010

    • Author(s)
      鈴木雄太郎
    • Journal Title

      Prog Neuropsychopharmacol Biol Psychiatry

      Volume: 34 Pages: 830-833

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] Customized pharmacotherapies in schizophrenia.2010

    • Author(s)
      鈴木雄太郎
    • Journal Title

      Nihon Shinkei Seishin Yakurigaku Zasshi

      Volume: 30 Pages: 77-81

    • NAID

      10029093250

    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] Fluvoxamineからparoxetineへ置換した際のうつ病患者における忍容性の違い.2010

    • Author(s)
      常山暢人, 鈴木雄太郎, 福井直樹, 須貝拓朗, 渡邉純蔵, 小野信, 染矢俊幸
    • Journal Title

      臨床精神薬理 13巻6号

      Pages: 1157-1161

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] The wide variability of perospirone metabolism and the effect of perospirone on prolactin in psychiatric patients.2010

    • Author(s)
      Suzuki Y, Sawamura K, Ono S, Fukui N, Sugai T, Watanabe J, Tsuneyama N, Inoue Y, Someya T
    • Journal Title

      Prog Neuropsychopharmacol Biol Psychiatry. 34

      Pages: 830-833

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] Differences in clinical effect and tolerance between fluvoxamine and paroxetine:A switching study in patients with depression.2010

    • Author(s)
      鈴木雄太郎
    • Journal Title

      Hum Psychopharmacol

      Volume: 25 Pages: 525-529

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] Hypoglycemia induced by second generation antipsychotic agents in non-diabetic schizophrenic patients.2009

    • Author(s)
      Suzuki Y Watanabe J Fukui N, Ozdemir V, Someya T
    • Journal Title

      BMJ (印刷中)

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19591344
  • [Journal Article] Hypoglycemia induced by second generation antipsychotic agents in non-diabetic schizophrenic patients.2009

    • Author(s)
      Suzuki Y, Watanabe J, Fukui N, Ozdemir V, Someya T
    • Journal Title

      BMJ 338

      Pages: 1792-1792

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] Concentration-response relationship for fluvoxamine using remission as an an endopoint A receiver peration characteristics curve analysis in major depression.2008

    • Author(s)
      鈴木 雄太郎
    • Journal Title

      Journal of Clinical Psychopharmacology 28(3)(In press)

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19591342
  • [Journal Article] Dose-dependent effect of the CYP2D6 genotype on the steady-state fluvoxamine concentration.2008

    • Author(s)
      Watanabe J, SuzukiY, Fukui N, Sugai T, Ono s, Inoue Y, Someya T
    • Journal Title

      Ther Drag Monit 30(6)

      Pages: 705-708

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19591344
  • [Journal Article] Concentration-responserelationship for fluvoxamine using remission as an endpoint : A receiver operating characteristics curve analysis in major depression2008

    • Author(s)
      Suzuki Y, Fukui N, Sawamura K, Sugai T, Watanabe J, Ono S, Inoue Y, Ozdemir V, Someya T
    • Journal Title

      J Clin Psychopharmacol 28(3)

      Pages: 325-328

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19591342
  • [Journal Article] Concentration-response relationship for fluvoxamine using remission as an endpoint : A receiver operating characteristics curve analysis in major depression.2008

    • Author(s)
      Suzuki Y, Fukui N, Sawamura K, Sugai T, Watanabe J, Ono S, Inoue Y, Ozdemir V, Someya T
    • Journal Title

      J Clin Psychopharmacol 28(3)

      Pages: 325-328

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] Concentration-response relationship for fluvoxamine using remission as an endpoint: A receiver operating characteristics curve analysis in major depression.2008

    • Author(s)
      Suzuki Y, Fukui N, Sawamura K, Sugai T, Watanabe J, Ono S, Inoue Y, Ozdemir V, Someya T
    • Journal Title

      J Clin Psychopharmacol 28(3)

      Pages: 325-328

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19591344
  • [Journal Article] TDM やpharmacogenetics を活用したうつ病の寛解導入2008

    • Author(s)
      小野信, 鈴木雄太郎, 染矢俊幸
    • Journal Title

      精神科治療学 23(3)

      Pages: 291-300

    • Data Source
      KAKENHI-PROJECT-19591342
  • [Journal Article] Concentration-response relationship for fluvoxamine using remission as an endpoint : a receiver operating characteristics curve analysis in major depression.2008

    • Author(s)
      Suzuki Y, Fukui N, Sawamura K, Sugai T, Watanabe J, Ono S, Inoue Y, Ozdemir V, Someya T
    • Journal Title

      J Clin Psychopharmacol. 28

      Pages: 325-328

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] Dose-dependent effect of the CYP2D6 genotype on the steady-state fluvoxamine concentration2008

    • Author(s)
      Watanabe J, Suzuki Y, Fukui N, Sugai T, Ono S, Inoue Y, Someya T
    • Journal Title

      Ther Drug Monit 30(6)

      Pages: 705-708

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19591342
  • [Journal Article] Concentration-response relationship for fluvoxamine using remission as an endpoint : A receiver operating characteristics curve analysis in major depression2008

    • Author(s)
      Suzuki Y, Fukui N, Sawamura K, Sugai T,Watanabe J, Ono S, Inoue Y, Ozdemir V, Someya T
    • Journal Title

      J Clin Psychopharmacol 28(3)

      Pages: 325-328

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19591344
  • [Journal Article] Dose-dependent effect of the CYP2D6 genotype on the steady-state fluvoxamine concentration.2008

    • Author(s)
      Watanabe J, Suzuki Y, Fukui N, Sugai T, Ono S, Inoue Y, Someya T
    • Journal Title

      Ther Drug Monit. 30

      Pages: 705-708

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] 寛解を目指したフルボキサミンによるうつ病治療2008

    • Author(s)
      福井直樹, 鈴木雄太郎, 小野信, 染矢俊幸
    • Journal Title

      最新精神医学 13(5)

      Pages: 429-433

    • Data Source
      KAKENHI-PROJECT-19591342
  • [Journal Article] SSRI によって惹起される副作用の予測は可能か2008

    • Author(s)
      須貝拓朗, 鈴木雄太郎, 福井直樹, 渡邉純蔵, 小野信, 井上義政, 染矢俊幸
    • Journal Title

      精神神経学雑誌 110(8)

      Pages: 645-651

    • NAID

      10024578692

    • Data Source
      KAKENHI-PROJECT-19591342
  • [Journal Article] イミプラミン換算150mg以上/日はすべての患者にとって「十分な投与量」ではない?2007

    • Author(s)
      福井直樹, 鈴木雄太郎, 染矢俊幸
    • Journal Title

      薬局 58(3)

      Pages: 425-430

    • Data Source
      KAKENHI-PROJECT-19591342
  • [Journal Article] SSRIの副作用をどう予測するか2007

    • Author(s)
      須貝拓朗, 鈴木雄太郎, 染矢俊幸
    • Journal Title

      臨床精神薬理 10(8)

      Pages: 1447-1454

    • Data Source
      KAKENHI-PROJECT-19591342
  • [Journal Article] 薬物動態および薬力学(臨床効果, 副作用)の予測2007

    • Author(s)
      福井直樹, 鈴木雄太郎, 染矢俊幸
    • Journal Title

      オーダーメイド薬物治療. 月刊Mebio 24(2)

      Pages: 108-117

    • Data Source
      KAKENHI-PROJECT-19591342
  • [Journal Article] Dose-dependent effects of the 3435C>T genotype of ABCB1 gene on the steady-state plasma concentration of fluvoxamine in psychiatric patients.2007

    • Author(s)
      Fukui N, Suzuki Y, Sawamura K, Sugai T, Watanabe J, Inoue Y, Someya T
    • Journal Title

      Ther Drug Monit 29(2)

      Pages: 185-189

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19591344
  • [Journal Article] Dose-dependent effects of the 3435C>T genotype of ABCB1 gene on the steady-state plasma concentration of fluvoxamine in psychiatric patients2007

    • Author(s)
      Fukui N, Suzuki Y, Sawamura K, Sugai T, Watanabe J, Inoue Y, Someya T
    • Journal Title

      Ther Drug Monit 29(2)

      Pages: 185-189

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19591342
  • [Journal Article] 選択的セロトニン再取り込み阻害薬の治療反応性および副作用出現の予測に関する分子薬理遺伝学的研究2007

    • Author(s)
      小野信, 鈴木雄太郎, 染矢俊幸
    • Journal Title

      脳と精神の医学 18(1)

      Pages: 27-33

    • NAID

      10029854175

    • Data Source
      KAKENHI-PROJECT-19591342
  • [Journal Article] Dose-dependent effects of the 3435 C>T genotype of ATP-binding cassette subfamily B member 1 (ABCB1) gene on the steady-state plasma concentration of fluvoxamine in psychiatric patients.2007

    • Author(s)
      Fukui N, Suzuki Y, Sawamura S, Sugai T, Watanabe J, Inoue Y, Someya T
    • Journal Title

      Ther Drug Monit. (印刷中)

    • Data Source
      KAKENHI-PROJECT-17591199
  • [Journal Article] Dose-dependent effect of the 3435 C>T genotype of ABCB1 gene on the steady-state plasma concentration of fluvoxamine in psychiatric patients2007

    • Author(s)
      Fukui N, Suzuki Y, Sawamura K Sugai T, Watanabe J, Inoue Y, Someya T
    • Journal Title

      Ther Drug Monit 29(2)

      Pages: 185-189

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19591344
  • [Journal Article] The effect of 5-hydroxytryptamine 3A and 3B receptor genes on nausea induced by paroxetine.2006

    • Author(s)
      Sugai T, Suzuki Y, Sawamura K, Fukui N, Inoue Y, Someya T
    • Journal Title

      Pharmacogenomics J. 6(5)

      Pages: 351-356

    • Data Source
      KAKENHI-PROJECT-17591199
  • [Journal Article] Polymorphisms in the 5-hydroxytryptamine 2A receptor and cytochrome P4502D6 genes synergistically predict fluvoxamine-induced side effects in Japanese depressed patients.2006

    • Author(s)
      Suzuki Y.
    • Journal Title

      Neuropsychopharmacology. 31(4)

      Pages: 825-831

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-17591199
  • [Journal Article] Gender differences in prolactin elevation induced by olanzapine in Japanese drug-naive schizophrenic patients.2006

    • Author(s)
      Sawamura K, Suzuki Y, Fukui N, Sugai T, Someya T
    • Journal Title

      Prog Neuropsychopharmacol Biol Psychiatry. 30(8)

      Pages: 1511-1514

    • Data Source
      KAKENHI-PROJECT-17591199
  • [Journal Article] Polymorphisms in 5-hydroxytryptamine 2A receptor gene and cytochrome P4502D6 gene synergistically predict fluvoxamine-induced side effects in Japanese depressed patients.2006

    • Author(s)
      鈴木 雄太郎
    • Journal Title

      Neuropsychopharmacology 31・4

      Pages: 825-831

    • Data Source
      KAKENHI-PROJECT-17790807
  • [Journal Article] Polymorphisms in the 5-hydroxytryptamine 2A receptor and cytochrome P4502D6 genes synergistically predict fluvoxamine-induced side effects in Japanese depressed patients.2006

    • Author(s)
      Suzuki Y
    • Journal Title

      Neuropsychopharmacology. 31(4)

      Pages: 825-831

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-17591199
  • [Journal Article] Polymorphisms in the 5-hydroxytryptamine 2A receptor and cytochrome P4502D6 genes synergistically predict fluvoxamine-induced side effects in Japanese depressed patients.2006

    • Author(s)
      Suzuki Y, Sawamura K, Someya T
    • Journal Title

      Neuropsychopharmacology. 31(4)

      Pages: 825-831

    • Data Source
      KAKENHI-PROJECT-17591199
  • [Journal Article] Polymorphisms in the 5-Hydroxytryptamine 2A Receptor and CytochromeP4502D6 Genes Synergistically Predict Fluvoxamine-Induced Side Effects in Japanese Depressed Patients.2005

    • Author(s)
      鈴木 雄太郎
    • Journal Title

      Neuropsychopharmacology 5(Epub ahead of print)(電子出版)

    • Data Source
      KAKENHI-PROJECT-17790807
  • [Journal Article] Polymorphisms in 5-hydroxytryptamine 2A receptor gene and cytochrome P4502D6 gene synergistically predict fluvoxamine-induced side effects in Japanese depressed patients.2005

    • Author(s)
      Suzuki Y, Sawamura K, Someya T
    • Journal Title

      Neuropsychopharmacology Oct 5 (Epub ahead of print)

    • Data Source
      KAKENHI-PROJECT-17591199
  • [Journal Article] 新規抗精神病薬の相互作用2005

    • Author(s)
      福井直樹, 鈴木雄太郎, 染矢俊幸
    • Journal Title

      薬局 56(10)

      Pages: 2731-2737

    • Data Source
      KAKENHI-PROJECT-17591199
  • [Journal Article] うつ病及び統合失調症の薬物治療反応性に関する分子薬理遺伝学的研究

    • Author(s)
      鈴木雄太郎, 澤村一司, 染矢俊幸
    • Journal Title

      精神神経学雑誌 (印刷中)

    • NAID

      10018363802

    • Data Source
      KAKENHI-PROJECT-17591199
  • [Journal Article] Hypoglycemia induced by second generation antipsychotic agents in non-diabetic schizophrenic Patients

    • Author(s)
      Suzuki Y, Watanabe J, Fukui N, Ozdemir V, Someya T
    • Journal Title

      Br Med J (in press)

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19591344
  • [Journal Article] Hypoglycemia induced by second generation antipsychotic agents in non-diabetic schizophrenic patients.

    • Author(s)
      鈴木 雄太郎
    • Journal Title

      BMJ (In press)

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19591342
  • [Journal Article] The effect of 5-hydroxytryptamine 3A and 3B receptor genes on nausea induced by paroxetine.

    • Author(s)
      Sugai T, Suzuki Y, Sawamura K, Fukui N, Inoue Y, Someya T
    • Journal Title

      Pharmacogenomics J (in press)

    • Data Source
      KAKENHI-PROJECT-17591199
  • [Journal Article] Changes in the metabolic parameters and QTc interval after switching from olanzapine to aripiprazole in Japanese patients with stable schizophrenia.

    • Author(s)
      Suzuki Y, Sugai T, Ono S, Sawamura K, Fukui N, Watanabe J, Tsuneyama N, Someya T
    • Journal Title

      J Clin Psychopharmacol. in press

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] Concentration-response relationship for fluvoxamine using remission as an endpoint: A receiver operating characteristics curve analysis in major depression.

    • Author(s)
      Suzuki Y, Fukui N, Sawamura K, Sugai T, Watanabe J, Ono S, Inoue Y, Ozdemir V, Someya T
    • Journal Title

      J Clin Psychopharmacol (In press)

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19591344
  • [Journal Article] Dose-dependent increase in the QTc interval in aripiprazole treatment after risperidone.

    • Author(s)
      Suzuki Y, Shin Ono, Fukui N, Sugai T, Watanabe J, Tsuneyama N, Someya T
    • Journal Title

      Prog Neuropsychopharmacol Biol Psychiatry. in Press

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Journal Article] Hypoglycemia induced by second generation antipsychotic agents in non-diabetic schizophrenic patients

    • Author(s)
      Suzuki Y, Watanabe J, Fukui N, Ozdemir V, Someya T
    • Journal Title

      BMJ (in press)

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19591342
  • [Presentation] うつ病の治療反応性と血清DHEAS値との関連2023

    • Author(s)
      有波浩, 鈴木雄太郎, 田尻美寿々, 常山暢人, 染矢俊幸
    • Organizer
      第33回日本臨床精神神経薬理学会
    • Data Source
      KAKENHI-PROJECT-21K07478
  • [Presentation] うつ病および統合失調血清コルチゾール, インスリン様成長因子1値の増加と臨床症状との関連2022

    • Author(s)
      有波浩, 渡部雄一郎, 鈴木雄太郎, 田尻美寿々, 常山暢人, 染矢俊幸
    • Organizer
      第44回日本生物学的精神医学会・第32回日本臨床精神神経薬理学会・第52回日本神経精神薬理学会・第6回日本精神薬学会
    • Data Source
      KAKENHI-PROJECT-21K07478
  • [Presentation] うつ病診断の重要性と治療における最近の話題2021

    • Author(s)
      鈴木雄太郎
    • Organizer
      新潟市内科医会学術講演会
    • Data Source
      KAKENHI-PROJECT-21K07478
  • [Presentation] うつ病治療予測マーカーとしての血清コルチゾール値の可能性.2019

    • Author(s)
      常山暢人, 鈴木雄太郎, 有波浩, 田尻美寿々, 染矢俊幸
    • Organizer
      第29回日本臨床精神神経薬理学会
    • Data Source
      KAKENHI-PROJECT-17K10268
  • [Presentation] 血清IGF-1値, 血清cortisol値と統合失調症の重症度との関連.2019

    • Author(s)
      有波浩, 鈴木雄太郎, 田尻美寿々, 常山暢人, 染矢俊幸
    • Organizer
      第115回日本精神神経学会
    • Data Source
      KAKENHI-PROJECT-17K10268
  • [Presentation] うつ病治療予測マーカーとしての血清コルチゾール値の可能性.2019

    • Author(s)
      有波浩, 鈴木雄太郎, 田尻美寿々, 常山暢人, 染矢俊幸
    • Organizer
      第115回日本精神神経学会
    • Data Source
      KAKENHI-PROJECT-17K10268
  • [Presentation] 血清cortisol値, IGF-1値と統合失調症との関連.2019

    • Author(s)
      有波浩, 鈴木雄太郎, 田尻美寿々, 常山暢人, 染矢俊幸
    • Organizer
      第40回日本臨床薬理学会
    • Data Source
      KAKENHI-PROJECT-17K10268
  • [Presentation] 男性うつ病患者と血清estradiol値との関連.2019

    • Author(s)
      有波浩, 鈴木雄太郎, 田尻美寿々, 常山暢人, 染矢俊幸
    • Organizer
      第29回日本臨床精神神経薬理学会
    • Data Source
      KAKENHI-PROJECT-17K10268
  • [Presentation] 統合失調症と血清cortisol値, IGF-1値との関連.2019

    • Author(s)
      有波浩, 鈴木雄太郎, 田尻美寿々, 常山暢人, 染矢俊幸
    • Organizer
      第29回日本臨床精神神経薬理学会
    • Data Source
      KAKENHI-PROJECT-17K10268
  • [Presentation] うつ病治療反応性の予測マーカーの検討.2019

    • Author(s)
      有波浩, 鈴木雄太郎, 田尻美寿々, 常山暢人, 染矢俊幸
    • Organizer
      第40回日本臨床薬理学会
    • Data Source
      KAKENHI-PROJECT-17K10268
  • [Presentation] うつ病の重症度と血清cortisol値, IGF-1値, PRL値との関連.2019

    • Author(s)
      有波浩, 鈴木雄太郎, 田尻美寿々, 常山暢人, 染矢俊幸
    • Organizer
      第115回日本精神神経学会
    • Data Source
      KAKENHI-PROJECT-17K10268
  • [Presentation] 男性におけるうつ病重症度と血清estradiol値との関連.2019

    • Author(s)
      常山暢人, 鈴木雄太郎, 有波浩, 田尻美寿々, 染矢俊幸
    • Organizer
      第40回日本臨床薬理学会
    • Data Source
      KAKENHI-PROJECT-17K10268
  • [Presentation] 統合失調症の重症度と血清IGF-1値及びcortisol値との関連.2018

    • Author(s)
      有波浩, 鈴木雄太郎, 田尻美寿々, 常山暢人, 染矢俊幸
    • Organizer
      第28回日本臨床精神神経薬理学会
    • Data Source
      KAKENHI-PROJECT-17K10268
  • [Presentation] 血清cortisol値はうつ病治療反応性の予測マーカーとなり得るか?2018

    • Author(s)
      鈴木雄太郎, 有波浩, 田尻美寿々, 常山暢人, 染矢俊幸
    • Organizer
      第28回日本臨床精神神経薬理学会
    • Data Source
      KAKENHI-PROJECT-17K10268
  • [Presentation] うつ病の重症度と血清prolactin濃度との関連.2018

    • Author(s)
      有波浩, 鈴木雄太郎, 田尻美寿々, 常山暢人, 染矢俊幸
    • Organizer
      第15回日本うつ病学会
    • Data Source
      KAKENHI-PROJECT-17K10268
  • [Presentation] うつ病の重症度と血清prolactin濃度との関連.2018

    • Author(s)
      常山暢人, 鈴木雄太郎, 有波浩, 田尻美寿々, 染矢俊幸
    • Organizer
      第28回日本臨床精神神経薬理学会
    • Data Source
      KAKENHI-PROJECT-17K10268
  • [Presentation] Testosterone補充療法が奏功した抗うつ薬治療抵抗性うつ病の一症例.2018

    • Author(s)
      有波浩, 田崎正行, 鈴木雄太郎, 田尻美寿々, 常山暢人, 冨田善彦, 染矢俊幸
    • Organizer
      第114回日本精神神経学会
    • Data Source
      KAKENHI-PROJECT-17K10268
  • [Presentation] うつ病の重症度と血清IGF-1濃度との関連2017

    • Author(s)
      田尻美寿々、鈴木雄太郎、常山暢人、染矢俊幸
    • Organizer
      第14回日本うつ病学会
    • Data Source
      KAKENHI-PROJECT-17K10268
  • [Presentation] うつ病患者の血清cortisol及びIGF-1濃度が自殺関連症状に与える影響2017

    • Author(s)
      鈴木雄太郎、田尻美寿々、常山暢人、染矢俊幸
    • Organizer
      第27回日本臨床精神神経薬理学会
    • Data Source
      KAKENHI-PROJECT-17K10268
  • [Presentation] うつ病患者の重症度と血清IGF-1値, cortisol値, DHEAS値との関連2017

    • Author(s)
      田尻美寿々、鈴木雄太郎、常山暢人、染矢俊幸
    • Organizer
      第27回日本臨床精神神経薬理学会
    • Data Source
      KAKENHI-PROJECT-17K10268
  • [Presentation] うつ病患者における血清IGF-1と重症度の関連2017

    • Author(s)
      田尻美寿々、鈴木雄太郎、常山暢人、染矢俊幸
    • Organizer
      第10回新潟気分障害研究会
    • Data Source
      KAKENHI-PROJECT-17K10268
  • [Presentation] うつ病患者の重症度と血清IGF-1濃度との関連2017

    • Author(s)
      田尻美寿々、鈴木雄太郎、常山暢人、染矢俊幸
    • Organizer
      第5回新潟大学医学系基礎・臨床交流会
    • Data Source
      KAKENHI-PROJECT-17K10268
  • [Presentation] 単純型統合失調症をプロトタイプとした「青年期認知機能障害」に対する薬物療法の効果・安全性について-効果についての検討-.2016

    • Author(s)
      常山暢人、鈴木雄太郎、大竹裕美、染矢俊幸
    • Organizer
      第26回日本臨床精神神経薬理学会
    • Place of Presentation
      ホルトホール大分(大分県大分市)
    • Year and Date
      2016-11-17
    • Data Source
      KAKENHI-PROJECT-26461715
  • [Presentation] 単純型統合失調症をプロトタイプとした「青年期認知機能障害」に対する薬物療法の効果・安全性について-安全性についての検討-.2016

    • Author(s)
      大竹裕美、鈴木雄太郎、常山暢人、染矢俊幸
    • Organizer
      第26回日本臨床精神神経薬理学会
    • Place of Presentation
      ホルトホール大分(大分県大分市)
    • Year and Date
      2016-11-17
    • Data Source
      KAKENHI-PROJECT-26461715
  • [Presentation] 単純型統合失調症をプロトタイプとした「青年期認知機能障害」に対する薬物療法の効果についての検討.2016

    • Author(s)
      常山暢人、鈴木雄太郎、大竹裕美、染矢俊幸
    • Organizer
      第37回日本臨床薬理学会
    • Place of Presentation
      米子コンベンションセンター(鳥取県米子市)
    • Year and Date
      2016-12-02
    • Data Source
      KAKENHI-PROJECT-26461715
  • [Presentation] Aripiprazoleにより認知機能低下及び脳血流低下の改善を認めた「青年期認知機能障害」の1例2015

    • Author(s)
      大竹裕美、鈴木雄太郎、常山暢人、田尻美寿々、小田野幾雄、染矢俊幸
    • Organizer
      第25回日本臨床精神神経薬理学会
    • Place of Presentation
      京王プラザホテル(東京都)
    • Year and Date
      2015-10-29
    • Data Source
      KAKENHI-PROJECT-26461715
  • [Presentation] Aripiprazole, quetiapine内服にて糖負荷試験時のインクレチン反応性が変化した症例について2014

    • Author(s)
      小野信, 鈴木雄太郎, 福井直樹, 須貝拓朗, 渡邉純蔵, 常山暢人, 齋藤摩美, 田尻美寿々, 染矢俊幸
    • Organizer
      第24回日本臨床精神神経薬理学会
    • Place of Presentation
      名古屋国際会議場(名古屋)
    • Year and Date
      2014-11-20
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Presentation] 統合失調症患者が抱える身体リスク-外来患者と入院患者の違い-2014

    • Author(s)
      須貝拓朗, 鈴木雄太郎, 山崎學, 下田和孝, 森隆夫, 菅原典夫, 古郡規雄, 染矢俊幸
    • Organizer
      第24回日本臨床精神神経薬理学会
    • Place of Presentation
      名古屋国際会議場(名古屋)
    • Year and Date
      2014-11-20
    • Invited
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Presentation] 日本人入院統合失調症患者におけるメタボリックシンドローム有病率の特徴とその予測2014

    • Author(s)
      須貝拓朗, 鈴木雄太郎, 福井直樹, 渡邉純蔵, 小野信, 常山暢人, 齋藤摩美, 田尻美寿々, 染矢俊幸
    • Organizer
      第24回日本臨床精神神経薬理学会
    • Place of Presentation
      名古屋国際会議場(名古屋)
    • Year and Date
      2014-11-20
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Presentation] Aripiprazoleが心電図PR及びQT間隔に与える影響2014

    • Author(s)
      田尻美寿々, 鈴木雄太郎, 常山暢人, 須貝拓朗, 福井直樹, 渡邉純蔵, 小野信, 斎藤摩美, 染矢俊幸
    • Organizer
      第24回日本臨床精神神経薬理学会
    • Place of Presentation
      名古屋
    • Year and Date
      2014-11-20
    • Data Source
      KAKENHI-PROJECT-26461715
  • [Presentation] 抗精神病薬による体重増加及び糖脂質代謝異常への対応2014

    • Author(s)
      鈴木雄太郎
    • Organizer
      第110回日本精神神経学会
    • Place of Presentation
      パシフィコ横浜(横浜)
    • Year and Date
      2014-06-27
    • Invited
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Presentation] 日本人統合失調症入院患者における低体重および低栄養の有病率について2014

    • Author(s)
      斎藤摩美, 鈴木雄太郎, 須貝拓朗, 福井直樹, 渡邉純蔵, 小野信, 常山暢人, 染矢俊幸
    • Organizer
      第24回日本臨床精神神経薬理学会
    • Place of Presentation
      名古屋国際会議場(名古屋)
    • Year and Date
      2014-11-20
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Presentation] 統合失調症患者の身体モニタリング-これまでの報告と今できること-2014

    • Author(s)
      菅原典夫, 古郡規雄, 山崎學, 下田和孝, 森隆夫, 尾関祐二, 南良武, 岡本呉賦, 寒河江豊明, 松田ひろし, 須貝拓朗, 鈴木雄太郎, 染矢俊幸
    • Organizer
      第24回日本臨床精神神経薬理学会
    • Place of Presentation
      名古屋国際会議場(名古屋)
    • Year and Date
      2014-11-20
    • Invited
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Presentation] 抗うつ薬双極性障害治療薬の重篤な副作用の基本2014

    • Author(s)
      鈴木雄太郎
    • Organizer
      第11回日本うつ病学会
    • Place of Presentation
      広島国際会議場(広島)
    • Year and Date
      2014-07-18
    • Invited
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Presentation] 統合失調症およびTrib1遺伝子が脂質プロファイルへ与える影響について2014

    • Author(s)
      福井直樹, 鈴木雄太郎, 須貝拓朗, 渡邉純蔵, 小野信, 常山暢人, 齋藤摩美, 田尻美寿々, 染矢俊幸
    • Organizer
      第24回日本臨床精神神経薬理学会
    • Place of Presentation
      名古屋国際会議場(名古屋)
    • Year and Date
      2014-11-20
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Presentation] シンポジウム: 抗精神病薬治療の最適化 -副作用の視点から-.2011

    • Author(s)
      鈴木雄太郎
    • Organizer
      第21回日本臨床精神神経薬理学会(招待講演)
    • Place of Presentation
      東京
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Presentation] Olanzapineからaripiprazoleへの置換前後における糖脂質代謝関連因子及び心電図QT間隔の比較.2011

    • Author(s)
      鈴木雄太郎
    • Organizer
      第21回日本臨床精神神経薬理学会
    • Place of Presentation
      東京
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Presentation] 統合失調症治療における非定型抗精神病薬の副作用予測に関する研究.2010

    • Author(s)
      鈴木雄太郎、福井直樹、須貝拓朗、渡邉純蔵、小野信、常山暢人、染矢俊幸
    • Organizer
      第31回日本臨床薬理学会.
    • Place of Presentation
      京都
    • Year and Date
      2010-12-03
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Presentation] 統合失調症治療における第2世代抗精神病薬の副作用予測に関する研究2010

    • Author(s)
      鈴木雄太郎
    • Organizer
      第32回日本生物学的精神医学会
    • Place of Presentation
      北九州
    • Year and Date
      2010-10-08
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Presentation] 統合失調症治療における第2世代抗精神病薬の副作用予測に関する研究.2010

    • Author(s)
      鈴木雄太郎、福井直樹、須貝拓朗、渡邉純蔵、小野信、常山暢人、染矢俊幸
    • Organizer
      第32回日本生物学的精神医学会.
    • Place of Presentation
      北九州.
    • Year and Date
      2010-10-08
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Presentation] Perosphroneの薬物動態が血中prolactin濃度に与える影響2010

    • Author(s)
      鈴木雄太郎
    • Organizer
      第20回日本臨床精神神経薬理学会
    • Place of Presentation
      仙台
    • Year and Date
      2010-09-16
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Presentation] 統合失調症治療における非定型抗精神病薬の副作用予測に関する研究2010

    • Author(s)
      鈴木雄太郎
    • Organizer
      第31回日本臨床薬理学会
    • Place of Presentation
      京都
    • Year and Date
      2010-12-03
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Presentation] スタディグループ:抗精神病薬の選択基準-副作用で困った症例の検討-2010

    • Author(s)
      鈴木雄太郎
    • Organizer
      第20回日本臨床精神神経薬理学会
    • Place of Presentation
      仙台
    • Year and Date
      2010-09-05
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Presentation] 薬力学・薬物動態学に関する遺伝情報を用いたうつ病及び統合失調症治療について.2009

    • Author(s)
      鈴木雄太郎, 須貝拓朗, 福井直樹, 渡邉純蔵, 小野信, 常山暢人, 染矢俊幸
    • Organizer
      第19回日本臨床精神神経薬理学
    • Place of Presentation
      京都
    • Year and Date
      2009-11-13
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Presentation] 薬力学・薬物動態学に関する遺伝情報を用いたうつ病および統合失調症治療について2009

    • Author(s)
      鈴木雄太郎
    • Organizer
      第19回日本臨床精神神経薬理学会
    • Place of Presentation
      京都
    • Year and Date
      2009-11-13
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Presentation] 非定型抗精神病薬により惹起される低血糖発作.2008

    • Author(s)
      鈴木 雄太郎
    • Organizer
      第18回日本臨床精神神経薬理学会
    • Place of Presentation
      東京
    • Year and Date
      2008-10-02
    • Data Source
      KAKENHI-PROJECT-19591342
  • [Presentation] 45T/G single nucleotide polymorphism of the adiponectin gene is associated with olanzapine-induced weight gain.2008

    • Author(s)
      Sawamura K, Suzuki Y, Watanabe J, Ono S, Sugai T, Fukui N, Someya T
    • Organizer
      14^<th> Meeting of Pacific Rim Association for Clinical Pharmacogenetics
    • Place of Presentation
      Busan
    • Year and Date
      2008-04-10
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Presentation] オランザピンがアディポカイン変化に与える影響2008

    • Author(s)
      須貝拓朗, 鈴木雄太郎, 福井直樹, 渡邉純蔵小野信, 常山暢人, 染矢俊幸
    • Organizer
      第18回日本臨床精神神経薬理学会
    • Place of Presentation
      東京
    • Year and Date
      2008-10-03
    • Data Source
      KAKENHI-PROJECT-19591344
  • [Presentation] 寛解を目指したfluvoxamineによるうつ病治療の最適化.2008

    • Author(s)
      鈴木 雄太郎
    • Organizer
      第5回うつ病学会
    • Place of Presentation
      福岡
    • Year and Date
      2008-07-25
    • Data Source
      KAKENHI-PROJECT-19591342
  • [Presentation] 寛解を目指したfluvoxamineによるうつ病治療の最適化2008

    • Author(s)
      鈴木雄太郎, 小野信, 福井直樹, 須貝拓朗, 澤村一司, 渡邉純蔵, 常山暢人,染矢俊幸
    • Organizer
      第5回うつ病学会
    • Place of Presentation
      福岡
    • Data Source
      KAKENHI-PROJECT-19591342
  • [Presentation] Dose-dependent effects of the 3435 C>T genotype of ABCB1 gene on the steady-state plasma concentration of fluvoxamine2008

    • Author(s)
      Fukui N, Suzuki Y, Sawamura K, Sugai T, Watanabe J, Ono S, Tsuneyama N, Inoue Y, Someya T
    • Organizer
      14th Meeting of Pacific Rim Association for Clinical Pharmacogenetics
    • Place of Presentation
      Busan
    • Year and Date
      2008-04-10
    • Data Source
      KAKENHI-PROJECT-19591342
  • [Presentation] シンポジウム : SSRIによって惹起される副作用の予測は可能か?2008

    • Author(s)
      須貝拓朗, 鈴木雄太郎, 澤村一司, 福井直樹, 渡邉純蔵, 小野信, 井上義政, 染矢俊幸
    • Organizer
      第104回日本精神神経学会
    • Place of Presentation
      東京
    • Year and Date
      2008-05-29
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Presentation] シンポジウム: SSRIによって惹起される副作用の予測は可能か?2008

    • Author(s)
      須貝拓朗, 鈴木雄太郎, 澤村一司, 福井直樹, 渡邉純蔵, 小野信, 井上義政, 染矢俊幸
    • Organizer
      第104回日本精神神経学会
    • Place of Presentation
      東京
    • Year and Date
      2008-05-29
    • Data Source
      KAKENHI-PROJECT-20591362
  • [Presentation] シンポジウム : SSRIによって惹起される副作用の予測は可能か?2008

    • Author(s)
      須貝拓朗, 鈴木雄太郎, 澤村一司, 福井直樹, 渡邉純蔵, 小野信, 井上義政,染矢俊幸
    • Organizer
      第104回日本精神神経学会
    • Place of Presentation
      東京
    • Year and Date
      2008-05-29
    • Data Source
      KAKENHI-PROJECT-19591342
  • [Presentation] Tandem effects of cytochromeP4502D6 genotype and smoking on steady-state fluvoxamine concentration : a prospective dose-ranging study in Japanese psychiatric patients2008

    • Author(s)
      Sugai T, Suzuki Y, Fukui N, Watanabe J, Sawamura K, Inoue Y, Ozdemir V, Someya T
    • Organizer
      14th Meeting of Pacific Rim Association for Clinical Pharmacogenetics
    • Place of Presentation
      Busan
    • Year and Date
      2008-04-10
    • Data Source
      KAKENHI-PROJECT-19591342
  • [Presentation] シンポジウム : SSRIによって惹起される副作用の予測は可能か?2008

    • Author(s)
      須貝拓朗, 鈴木雄太郎, 澤村一司, 福井直樹, 渡邉純蔵, 小野信, 井上義政, 染矢俊幸
    • Organizer
      第104回日本精神神経学会
    • Place of Presentation
      東京
    • Year and Date
      2008-05-29
    • Data Source
      KAKENHI-PROJECT-19591344
  • [Presentation] CYP2C19遺伝子多型が定常状態fluvoxamine血中濃度に与える影響2007

    • Author(s)
      鈴木雄太郎, 福井直樹, 渡邉純蔵, 澤村一司, 須貝拓朗, 小野信, 熊田智, 井上義政, 染矢俊幸
    • Organizer
      第17回日本臨床精神神経薬理学会
    • Place of Presentation
      大阪
    • Year and Date
      2007-10-04
    • Data Source
      KAKENHI-PROJECT-19591344
  • [Presentation] CYP2C19遺伝子多型が定常状態fluvoxamine血中濃度に与える影響2007

    • Author(s)
      鈴木雄太郎, 福井直樹, 渡邉純蔵, 澤村一司, 須貝拓朗, 小野信, 熊田智,井上義政, 染矢俊幸
    • Organizer
      第17回日本臨床精神神経薬理学会
    • Place of Presentation
      大阪
    • Year and Date
      2007-10-04
    • Data Source
      KAKENHI-PROJECT-19591342
  • [Presentation] フルボキサミン治療反応性と治療開始時HAM-D symptom cluster との関係についての検討2007

    • Author(s)
      小野信, 鈴木雄太郎, 須貝拓朗, 福井 直樹, 澤村一司, 渡邉純蔵, 熊田智, 染矢俊幸
    • Organizer
      第17回日本臨床精神神経薬理学会
    • Place of Presentation
      大阪
    • Year and Date
      2007-10-05
    • Data Source
      KAKENHI-PROJECT-19591342
  • [Presentation] 悪性症候群とドーパミンD3受容体遺伝子多型との関連研究2007

    • Author(s)
      須貝拓朗, 鈴木雄太郎, 福井直樹, 澤村一司, 渡邉純蔵, 小野信, 熊田智, 染矢俊幸
    • Organizer
      第29回日本生物学的精神医学会
    • Place of Presentation
      札幌
    • Year and Date
      2007-07-13
    • Data Source
      KAKENHI-PROJECT-19591344
  • [Presentation] 抗うつ薬の副作用予測

    • Author(s)
      鈴木雄太郎
    • Organizer
      第22回日本臨床精神神経薬理学会
    • Place of Presentation
      宇都宮
    • Invited
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Presentation] 抗精神病薬治療と身体リスクに関する合同プロジェクト委員会: 抗精神病薬と糖・脂質代謝異常.

    • Author(s)
      ○須貝拓朗, 鈴木雄太郎, 山崎學, 森隆夫, 下田和孝, 古郡規雄, 菅原典夫, 福井直樹, 渡邉純蔵, 小野信, 常山暢人, 斎藤摩美, 染矢俊幸
    • Organizer
      第34回日本臨床薬理学会
    • Place of Presentation
      東京
    • Invited
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Presentation] 抗精神病薬と身体リスク

    • Author(s)
      鈴木雄太郎
    • Organizer
      第1回日本精神科医学会
    • Place of Presentation
      大阪
    • Invited
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Presentation] Olanzapineからrisperidoneへの置換前後におけるPR及びQT間隔の変化.

    • Author(s)
      ○鈴木雄太郎, 須貝拓朗, 小野信, 澤村一司, 福井直樹, 渡邉純蔵, 常山暢人, 斎藤摩美, 染矢俊幸
    • Organizer
      第23回日本臨床精神神経薬理学会
    • Place of Presentation
      沖縄
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Presentation] 抗精神病薬治療と身体リスクに関する合同プロジェクト委員会: 日本人外来統合失調症患者におけるメタボリックシンドロームの有病率とその特徴 -日精協全国モニタリング調査(2012)から-.

    • Author(s)
      ○須貝拓朗, 鈴木雄太郎, 山崎學, 下田和孝, 森隆夫, 古郡規雄, 菅原典夫, 染矢俊幸
    • Organizer
      第23回日本臨床精神神経薬理学会
    • Place of Presentation
      沖縄
    • Invited
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Presentation] 抗精神病薬と身体リスク

    • Author(s)
      鈴木雄太郎
    • Organizer
      第22回日本臨床精神神経薬理学会
    • Place of Presentation
      宇都宮
    • Invited
    • Data Source
      KAKENHI-PROJECT-23591670
  • [Presentation] 抗精神病薬治療と身体リスクに関する合同プロジェクト委員会: 統合失調症患者が抱える身体リスクの現状について.

    • Author(s)
      ○須貝拓朗, 鈴木雄太郎, 山崎學, 下田和孝, 森隆夫, 菅原典夫, 古郡規雄, 染矢俊幸
    • Organizer
      第2回日本精神科医学会
    • Place of Presentation
      さいたま
    • Invited
    • Data Source
      KAKENHI-PROJECT-23591670
  • 1.  SOMEYA Toshiyuki (50187902)
    # of Collaborated Projects: 5 results
    # of Collaborated Products: 91 results
  • 2.  SAWAMURA Kazushi (60444155)
    # of Collaborated Projects: 4 results
    # of Collaborated Products: 23 results
  • 3.  FUKUI Naoki (90535163)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 26 results
  • 4.  TSUNEYAMA Nobuto (90750349)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 7 results
  • 5.  MURATAKE Tatsuyuki (60311669)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi